EUCTR2019-002535-28-FR进行中（未招募）1 期
Braking effect on myopia with atropine eye drops at 0.01%. - Myopia stop
Hôpitaux Universitaires de Strasbourg0 个研究点目标入组 160 人开始时间: 2019年9月30日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •-- Children with myopia between -1 and -6 spherical diopters measured under cycloplegia with an automatic refractor.
- •- Progressive myopia characterized by a minimal rate of progression of -0.75 diopters in the last 12 months
- •- Age between 4 and 12 years old included at the time of signing the consent.
- •- Negative urinary pregnancy test for women of childbearing age using an effective contraceptive method (oral, intravaginal or transdermal estroprogestogenic hormonal contraception or oral, subcutaneous, injectable or intrauterine device, or intrauterine hormonal device, occlusion sterilization of the fallopian tubes, sexual abstinence)
- •- Consent to participate in the study signed by both parents of the child.
- •- Subject affiliated to a social security health insurance scheme.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 160
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Astigmatism = with 1.5 diopters
- •- Anisometropy = with 2 diopters
- •- Presence of an ocular surface or corneal pathology (recurrent keratalgia, keratoconus)
- •- Presence of a pathology of the anterior segment (Iranian malformation, cataract)
- •- Presence of a pathology of the posterior or retinal segment (dystrophies or acquired diseases)
- •- Presence of an old or progressive inflammatory pathology (uveitis)
- •- Presence of strabismus or disturbance of stereoscopic vision (Lang Test not seen)
- •- Presence of amblyopia
- •- Contraindication to the use of the investigational medicinal product and/or to the explorations provided for in the protocol
- •- Hypersensitivity to atropine or any of the excipients of the eye drops present in the raw material
- •- Impossibility of giving the subject informed information (subject in an emergency situation, difficulties in understanding the subject, etc.)
- •- Subjects treated with psychotropic drugs
- •- Subjects with a psychiatric condition
- •- Subject under the protection of justice
- •- Subject under guardianship or curatorship
- •- Pregnant and breastfeeding women
- •-Women capable of procreation (from first menstruation to menopause) not using contraceptive methods. In the event of a first menstruation occurring during the subject's participation, a urinary pregnancy test will be performed and an effective method of contraception will be initiated (oral, intravaginal or transdermal estroprogestogenic hormonal contraception or oral, subcutaneous, injectable or progestin-only hormonal contraception or intrauterine device, or intrauterine hormonal device, fallopian tube occlusion sterilization, sexual abstinence)
研究者
相似试验
已完成
2 期
Effect of low dose atropine eye drops on eye-related changes at near focal distances in children and young adultsACTRN12621000563864Queensland University of Technology31
已完成
1 期
Effect of atropine eye drops on thinning of the ocular choroid induced by retinal image defocus in adults with myopia (near-sightedness)MyopiaACTRN12617001519347The University of Auckland12
已完成
不适用
Combined effect of atropine eye drops and retinal defocus on the thickness of the ocular choroid in children with myopia.Eye - Diseases / disorders of the eyeMyopiaACTRN12620000052932The University of Auckland20
已完成
2 期
Effect of 0.01% atropine eye drops in children with moderate to high grade myopiarefractive error, development, childD009216MyopiaJPRN-jRCTs061180091Hasebe Satoshi18
撤回
3 期
Effect of adding atropine to orthokeratology on eye elongation and myopia progression in children.Myopia (short-sight)Eye - Diseases / disorders of the eyeACTRN12620001046998The University of Auckland32